Remiges tops off $80M biotech fund

Remiges Ventures raised $10 million in the second and final close of Remiges BioPharma Fund L.P., bringing the fund's total to $80 million.

New LP UTokyo Innovation Platform, the University of Tokyo's strategic investment arm, joined existing LPs Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506) and 1Globe Capital...